Commitment of human mesenchymal stromal cells to skeletal lineages is independent of their morphogenetic capacity

被引:0
作者
Marin-Llera, Jessica Cristina [1 ]
Garcia-Garcia, Damian [1 ]
Garay-Pacheco, Estefania [1 ]
Cortes-Morales, Victor Adrian [2 ]
Montesinos-Montesinos, Juan Jose [2 ]
Chimal-Monroy, Jesus [3 ,4 ]
机构
[1] Univ Nacl Autonoma Mexico, Med Genom & Toxicol Ambiental, Inst Invest Biomed, Coyoacan 04510, Mexico
[2] Hosp Oncol Ctr Med Nacl Siglo XXI, Unidad Invest Med Enfermedades Oncol, Lab Celulas Troncales Mesenquimales, Inst Mexicano Seguro Social, Mexico City 06720, Mexico
[3] Univ Nacl Autonoma Mexico, Dept Med Genomica & Toxicol Ambiental, Inst Invest Biomed, Coyoacan 04510, Mexico
[4] Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, Ciudad Univ,Apartado Postal 70228, Coyoacan 04510, Mexico
来源
WORLD JOURNAL OF STEM CELLS | 2023年 / 15卷 / 07期
关键词
Human mesenchymal stromal cells; Recombinant limbs; Mesenchymal stromal cell morphogenesis; Mesenchymal stromal cell in vivo differentiation; Skeletal tissues; STEM-CELLS; BONE-FORMATION; HOMEOBOX GENE; DIFFERENTIATION; EXPRESSION; MORPHOLOGY; SCLERAXIS; TENDONS; CBFA1; MODEL;
D O I
10.4252/wjsc.v15.i7.701
中图分类号
Q813 [细胞工程];
学科分类号
摘要
BACKGROUNDMesenchymal stromal cells (MSCs) are multipotent cell populations obtained from fetal and adult tissues. They share some characteristics with limb bud mesodermal cells such as differentiation potential into osteogenic, chondrogenic, and tenogenic lineages and an embryonic mesodermal origin. Although MSCs differentiate into skeletal-related lineages in vitro, they have not been shown to self-organize into complex skeletal structures or connective tissues, as in the limb. In this work, we demonstrate that the expression of molecular markers to commit MSCs to skeletal lineages is not sufficient to generate skeletal elements in vivo.AIMTo evaluate the potential of MSCs to differentiate into skeletal lineages and generate complex skeletal structures using the recombinant limb (RL) system.METHODSWe used the experimental system of RLs from dissociated-reaggregated human placenta (PL) and umbilical cord blood (UCB) MSCs. After being harvested and reaggregated in a pellet, cultured cells were introduced into an ectodermal cover obtained from an early chicken limb bud. Next, this filled ectoderm was grafted into the back of a donor chick embryo. Under these conditions, the cells received and responded to the ectoderm's embryonic signals in a spatiotemporal manner to differentiate and pattern into skeletal elements. Their response to differentiation and morphogenetic signals was evaluated by quantitative polymerase chain reaction, histology, immunofluorescence, scanning electron microscopy, and in situ hybridization.RESULTSWe found that human PL-MSCs and UCB-MSCs constituting the RLs expressed chondrogenic, osteogenic, and tenogenic molecular markers while differentially committing into limb lineages but could not generate complex structures in vivo. MSCs-RL from PL or UCB were committed early to chondrogenic lineage. Nevertheless, the UCB-RL osteogenic commitment was favored, although preferentially to a tenogenic cell fate. These findings suggest that the commitment of MSCs to differentiate into skeletal lineages differs according to the source and is independent of their capacity to generate skeletal elements or connective tissue in vivo. Our results suggest that the failure to form skeletal structures may be due to the intrinsic characteristics of MSCs. Thus, it is necessary to thoroughly evaluate the biological aspects of MSCs and how they respond to morphogenetic signals in an in vivo context.CONCLUSIONPL-MSCs and UCB-MSCs express molecular markers of differentiation into skeletal lineages, but they are not sufficient to generate complex skeletal structures in vivo.
引用
收藏
页码:701 / 712
页数:12
相关论文
共 39 条
  • [1] Bone marrow-derived mesenchymal stem cells transplantation ameliorates renal injury through anti-fibrotic and anti-inflammatory effects in chronic experimental renovascular disease
    Almeida, Aline
    Lira, Rafaelle
    Oliveira, Mariana
    Martins, Marcela
    Azevedo, Yanca
    Silva, Karina R.
    Carvalho, Simone
    Cortez, Erika
    Stumbo, Ana Carolina
    Carvalho, Lais
    Thole, Alessandra
    [J]. BIOMEDICAL JOURNAL, 2022, 45 (04) : 629 - 641
  • [2] HIF1α regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis
    Amarilio, Roy
    Viukov, Sergey V.
    Sharir, Amnon
    Eshkar-Oren, Idit
    Johnson, Randall S.
    Zelzer, Elazar
    [J]. DEVELOPMENT, 2007, 134 (21): : 3917 - 3928
  • [3] Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23
  • [4] Runx2 Regulates Endochondral Ossification Through Control of Chondrocyte Proliferation and Differentiation
    Chen, Haiyan
    Ghori-Javed, Farah Y.
    Rashid, Harunur
    Adhami, Mitra D.
    Serra, Rosa
    Gutierrez, Soraya E.
    Javed, Amjad
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (12) : 2653 - 2665
  • [5] Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis:: Sox genes and BMP signaling
    Chimal-Monroy, J
    Rodriguez-Leon, J
    Montero, JA
    Gañan, Y
    Macias, D
    Merino, R
    Hurle, JM
    [J]. DEVELOPMENTAL BIOLOGY, 2003, 257 (02) : 292 - 301
  • [6] Understanding the Cellular and Molecular Mechanisms That Control Early Cell Fate Decisions During Appendicular Skeletogenesis
    Cristina Marin-Llera, Jessica
    Garciadiego-Cazares, David
    Chimal-Monroy, Jesus
    [J]. FRONTIERS IN GENETICS, 2019, 10
  • [7] Fu Y, 2017, TISSUE ENG PART B-RE, V23, P515, DOI [10.1089/ten.teb.2016.0365, 10.1089/ten.TEB.2016.0365]
  • [8] Artificial Kidney Capsule Packed with Mesenchymal Stem Cell-Laden Hydrogel for the Treatment of Rhabdomyolysis-Induced Acute Kidney Injury
    Fu, Zhangning
    Chu, Yanji
    Geng, Xiaodong
    Ma, Yingchao
    Chi, Kun
    Song, Chengcheng
    Liao, Shenglong
    Hong, Quan
    Wu, Di
    Wang, Yapei
    [J]. ACS BIOMATERIALS SCIENCE & ENGINEERING, 2022, 8 (04) : 1726 - 1734
  • [9] Mesenchymal stem cells and immunomodulation: current status and future prospects
    Gao, F.
    Chiu, S. M.
    Motan, D. A. L.
    Zhang, Z.
    Chen, L.
    Ji, H-L
    Tse, H-F
    Fu, Q-L
    Lian, Q.
    [J]. CELL DEATH & DISEASE, 2016, 7 : e2062 - e2062
  • [10] Recombinant Limb Assay as in Vivo Organoid Model
    Garcia-Garcia, Roberto Damian
    Garay-Pacheco, Estefania
    Marin-Llera, Jessica Cristina
    Chimal-Monroy, Jesus
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10